Epidemiology of Multidrug-Resistant TB in Wisconsin Philip Wegner TB Nurse Consultant October 15, 2013.

Slides:

Advertisements

Similar presentations

Insurance 101 Terminology Presented for Wisconsin 4-H Youth Development Staff Youth Emphasis March 2005.

Advertisements

Special Rules for Higher-Priced Mortgage Loans Marci A. VanAdestine Edward J. Heiser, Jr. Ken R. Nowakowski Lisa M. Lawless Tim H. Posnanski Whyte Hirschboeck.

1 A CCESS TO E LIGIBILITY S UPPORT S ERVICES FOR H EALTH AND N UTRITION Usage and Eligibility Results Report As of 1/31/2010.

1 Highlights Highlights. 2 4-H Afterschool Team 4-H Afterschool Team Past 4-H Afterschool Team Chairs Past 4-H Afterschool Team Chairs –Gloria Fauerbach,

2013 Wisconsin Health Improvement and Research Partnerships Forum 12 September 2013 Union South, University of Wisconsin - Madison Betty A. Chewning, PhD.,

Building Epidemiologic Capacity in Wisconsin February 2005 Lorna Will RN, MA Surveillance Epidemiologist Wisconsin Division of Public Health.

World Tuberculosis Day 2015 The TB situation in 2013: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

Rare Plants in Wisconsin Right-of-ways Presentation prepared by: Wisconsin Transportation Information Center-LTAP University of Wisconsin-Madison.

1 ACCESS TO ELIGIBILITY SUPPORT SERVICES FOR HEALTH, NUTRITION, and CHILD CARE Usage and Eligibility Results Report As of 2/28/2013.

The Wisconsin Maps PowerPoint Created by Rozalynn M. Klaas, UW-Madison Applied Population LabRozalynn M. Klaas In cooperation with Bethany Laursen, UW-Extension’s.

TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.

WMLN October 2013 Wisconsin Department of Health Services WMLN October, 2013 Lorna Will RN, MA Wisconsin Division of Public Health TB Update Current Statistics.

Criteria for Cross-Jurisdictional Sharing in Public Health Perspectives from a literature review, health officers interviews and policymakers discussion.

North Central Wisconsin Regional Planning Commission VILAS COUNTY ALL HAZARD MITIGATION PLAN PLANNING PROCESS OVERVIEW Darryl L. Landeau, AICP – Senior.

2015 Northeast Region Utility Conference January 23, — 2016 Local Program.

State Data System: Incorporating ICWA Components MCWIC Tribal Gathering May 5, 2010 Loa Porter, MPA - Indian Child Welfare Consultant Wisconsin Department.

4 th National Anti-tuberculosis Drug Resistance Survey Botswana, 2007.

Figure 1. Number of Tuberculosis Cases: California, California Department of Public Health, Tuberculosis Control Branch Number of Tuberculosis.

The Changing Landscape of TB: Maryland TB in 2013 Presented by Dr. David Blythe Lisa Paulos, RN MPH, Epidemiologist Center for TB Control & Prevention.

Our ongoing study has been to survey local deer tick populations in a mile radius of Eau Claire for the presence of Borrelia burgdorferi bacteria.

Abstract Results Borrelia burgdorferi in Ixodes scapularis adult female ticks, Wisconsin Alyssa Kruger & Dr. Lloyd Turtinen Department of Biology.

Refugees and Immigrants in Wisconsin

Surveillance of Arbovirus Infections and Ehrlichiosis in Wisconsin

1 Epidemiology of Pediatric Tuberculosis in the United States, 1993–2006 Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis.

Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.

Tuberculosis Research of INA-RESPOND on Drug-resistant

WISCONSIN DEPARTMENT OF ADMINISTRATION Wisconsin Population Trends Patrick J. Farley Wisconsin Department of Administration Division of Intergovernmental.

Wisconsin STD Program Overview of Gonorrhea Epidemiology and Program Prevention Efforts Meeting February 2, 2010 Wisconsin Department of Health Services:

Access to Eligibility Support Services for Health, Nutrition, And Child Care Usage and Eligibility Results Report As of May 31, 2013.

TB 101 Part II Brenda Mayes, R. N. March TREATMENT TB DISEASE MDR XDR LATENT TB INFECTION.

Division of Tuberculosis Elimination Centers for Disease Control and Prevention Tuberculosis in the United States National Tuberculosis Surveillance System.

Tuberculosis in the United States National Tuberculosis Surveillance System Highlights from 2011 National Center for HIV/AIDS, Viral Hepatitis, STD, and.

2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 2,500 3,000 3,500 4,000 4,500 5,000 5,500 6,000 Figure 1. Number of Tuberculosis Cases: California,

Access to Eligibility Support Services for Health, Nutrition, and Child Care Usage and Eligibility Results Report As of March 31, 2014.

Steven Deller Department of Agricultural and Applied Economics University of Wisconsin – Madison/Extension The “Drivers” of Crime.

Re-Admission Rates: Population Characteristics and Data Accuracy Jay Ford Tim Conner.

2009 WISCONSIN DEPARTMENT OF NATURAL RESOURCES HUNTING INCIDENT REPORT PO B OX 7921 M ADISON WI PUB-LE-006 (Rev. 2/10)

Number of Tuberculosis Cases: California, Number of Tuberculosis Cases.

12/22/2015 Wisconsin Local Health Departments An Overview of Wisconsin Local Health Departments.

Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.

Late Breaking News. Current Makeup Senate: 18 Republicans – 15 Democrats Assembly: 60 Republicans – 39 Democrats 28 Retirements 21 Assembly 7 Senate 1.

Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.

Community-Academic Aging Research Network CAARN Jill Ballard, MPH, CHES September 2011.

By: Mpho Kontle and Topo Moses. Introduction & Etiology Multi-drug-resistant tuberculosis (MDR-TB) is defined as tuberculosis that is resistant to at.

Figure 1. Number of Tuberculosis Cases: California, Number of Tuberculosis Cases

Gundersen Lutheran Medical Center, Inc. | Gundersen Clinic, Ltd. The Business Case for Wellness Michael Richards Executive Director Gundersen Health System.

State of Family Planning & Reproductive Health WISCONSIN FAMILY PLANNING REPRODUCTIVE HEALTH ASSOCIATION.

TB Control Program County of San Diego County of San Diego Health and Human Services Agency Tuberculosis Control Branch Trends in Tuberculosis Highlights.

Deployment SVRS Conference for Wisconsin County Clerks May 4, 2005 – May 5, 2005.

1 Emission and Air Quality Trends Review Wisconsin July 2013.

Drug Enforcement Administration

World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.

TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.

Criteria for Cross-Jurisdictional Sharing in Public Health

Certified Peer Specialist

Wisconsin Caregiver Coalition Project

Aging Plan Reviewer Assignments

Long-Term Power Outage Regional Planning Workshop

COVERAGE MAP Rhinelander Wausau DMA Market Data* DMA Demographics

Wisconsin Caregiver Coalition Project

Tuberculosis in Wales Annual Report 2018 Data to the end of 2017

Protective Factors and Youth Thrive

Emission and Air Quality Trends Review

Certified Parent Peer Specialist

Certified Peer Specialists by County as of September 2012

Emission and Air Quality Trends Review

Tuberculosis in Wales Annual Report 2017 Data to the end of 2016

Presentation transcript:

Epidemiology of Multidrug-Resistant TB in Wisconsin Philip Wegner TB Nurse Consultant October 15, 2013

Protecting and promoting the health and safety of the people of Wisconsin 2  Definition: drug-resistance to at least isoniazid (INH) and Rifampin (RIF).  Normal treatment for TB is 6-9 months but for MDR-TB, treatment is for months post sputum culture conversion and usually totals months, plus the recommended 2-year follow-up monitoring. Background to Multidrug-resistant Tuberculosis (MDR-TB) “Treatment must be more aggressive in situations where the patient has long-standing disease (years), extensive disease, or multiple previous failed treatment efforts” -from Drug-Resistant Tuberculosis: A Survival Guide for Clinicians 2 nd edition, 2008 Francis J. Curry National TB Center in San Francisco, CA

Standards in MDR-TB Treatment  MDR-TB expertise is needed to manage each case.  More frequent laboratory collection and analysis is needed than with non-drug-resistant TB (second-line drug susceptibilities, therapeutic drug monitoring, longer sputum collection is needed to assess for treatment failure).  All treatment is individually based (medications, treatment response, monitoring and duration).  Guidelines –Francis J Curry National TB Center in San Francisco, CA 2 nd edition Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, Protecting and promoting the health and safety of the people of Wisconsin 3

4 MDR-TB in the United States  MDR-TB cases are 1.3% of all cases in the U.S. between (638 cases).  States with the highest number of MDR-TB cases are: California (162), New York (84), Texas (74) New Jersey (45).  States with the highest percentage of MDR-TB among their TB cases are: 1. Utah (3.6%), 2. Wisconsin (3.24%), 3. Connecticut (3.01%), 4. Hawaii (2.08%) and New Jersey (1.92%).  MDR-TB cases are 15.7% US-born and 84.3% Foreign-born.

MDR-TB in the U.S States with no MDR-TB cases (10) States with 1-10 MDR-TB cases (27 including D.C.) D.C. States with >10 MDR-TB cases (14)

Protecting and promoting the health and safety of the people of Wisconsin 6 Douglas Bayfield Ashland Sawyer Washburn Burnett Polk BarronRusk Price Iron Vilas Oneida Lincoln Taylor Chippewa St. Croix Pierce Dunn Pepin Eau Claire Buffalo Trempealeau Jackson Monroe Clark Marathon Wood Portage Juneau Adams Sauk LaCrosse Vernon Crawford Richland Grant LaFayette Green Rock Dane Iowa Columbia Dodge JeffersonWaukesha Walworth Kenosha Racine Ozaukee Sheboygan Fond du Lac Green Lake Marquette Waushara Winnebago Calumet Manitowoc Kewaunee Brown Outagamie Waupaca Shawano Menom- inee Oconto Langlade Forest Marinette Florence Door Milwaukee Washington 62-Counties with no MDR-TB 4-Counties with 1 MDR-TB case 3-Counties with 2-3 MDR-TB 2-Counties with >3 MDR-TB MDR-TB in Wisconsin (5)

Where MDR-TB has occurred in Wisconsin Protecting and promoting the health and safety of the people of Wisconsin 7

8 Who has MDR-TB in Wisconsin?

Average Age of MDR-TB patients in Wisconsin (Hmong and non-Hmong) Protecting and promoting the health and safety of the people of Wisconsin 9

MDR-TB Indicators (to date)  23 MDR-TB cases between (2.5/year average)  All are foreign-born and Asian (15 Hmong, 8 non-Hmong)  Average number years in U.S. before diagnosis = 9.9 years  Hmong =12.6 years (average age = 62)  Non-Hmong = 4.8 years (average age = 23)  8 did not complete treatment (6 current, 2 died)  91.3% pulmonary (21)  1 clinical case (4.3%) and 1 extrapulmonary (4.3%) Protecting and promoting the health and safety of the people of Wisconsin 10

Protecting and promoting the health and safety of the people of Wisconsin 11  Average length of treatment is 54 months (4.5 years) – excluding those who died, average = 42 months (3.5 years)  13 with cavitation (56.5%) indicating extensive disease  Culture-conversion average of 79 days for all;  For those with cavitation = 71 days  For those without cavitation = 91 days  Excluding one patient that was re-treated = 65 days  22 culture confirmed (1 by only a bronchoscopy), 1 clinical  2 died during treatment (8.6%), average of 77 years of age More MDR-TB Indicators (to date)